Anne Tierens
Papers
1
Total Citations
57
H-Index
1
About
Anne Tierens is a leading hematopathologist whose research has significantly advanced the understanding of B-cell lymphomas, particularly splenic marginal zone lymphoma (SMZL). Her seminal work in 2004 demonstrated that SMZL is characterized by the constitutive expression of AP-1 transcription factors (c-jun, junD, junB, c-fos) and the marginal zone B-cell transcription factor Notch2, providing critical insights into the molecular pathogenesis of this disease. This highly cited study (57 citations) established a foundational framework for distinguishing SMZL from other B-cell malignancies and highlighted key pathways involved in its development. Tierens’ contributions have been instrumental in refining diagnostic criteria and uncovering potential therapeutic targets for this rare lymphoma. Her research continues to influence the fields of hematopathology and lymphoma biology, offering valuable guidance for both clinicians and researchers working to improve patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1